For: | Xie XQ, Zhao QH, Wang H, Gu KS. Dysregulation of mRNA profile in cisplatin-resistant gastric cancer cell line SGC7901. World J Gastroenterol 2017; 23(7): 1189-1202 [PMID: 28275299 DOI: 10.3748/wjg.v23.i7.1189] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i7/1189.htm |
Number | Citing Articles |
1 |
Chunhui Lang, Miao Xu, Ziyi Zhao, Jinyao Chen, Lishi Zhang. MicroRNA‑96 expression induced by low‑dose cisplatin or doxorubicin regulates chemosensitivity, cell death and proliferation in gastric cancer SGC7901 cells by targeting FOXO1. Oncology Letters 2018; doi: 10.3892/ol.2018.9122
|
2 |
Caijin Zhou, Linxia Chen, Rihong Chen, Feipeng Xu, Zhe Huang, Renwei Huang, Weiwei Wang, Qingwen Xu. miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway. Journal of Chemotherapy 2022; 34(1): 35 doi: 10.1080/1120009X.2021.1936957
|
3 |
Rui Chen, Li‑Hong Huang, Yi‑Yao Gao, Jian‑Zeng Yang, Yan Wang. Identification of differentially expressed genes in MG63 osteosarcoma cells with drug‑resistance by microarray analysis. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9774
|
4 |
Amy M. Buckley, Becky AS. Bibby, Margaret R. Dunne, Susan A. Kennedy, Maria B. Davern, Breandán N. Kennedy, Stephen G. Maher, Jacintha O’Sullivan. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells. Pharmaceuticals 2019; 12(1): 33 doi: 10.3390/ph12010033
|
5 |
Adrian D. Schubert, Fernando T. Zamuner, Nyall R. London, Alex Zhavoronkov, Ranee Mehra, Mohammad O. Hoque, Atul Bedi, Rajani Ravi, Elana J. Fertig, David Sidransky, Daria A. Gaykalova, Evgeny Izumchenko. Molecular Determinants of Head and Neck Cancer. Current Cancer Research 2018; : 229 doi: 10.1007/978-3-319-78762-6_8
|
6 |
Marek Kos, Krzysztof Bojarski, Paulina Mertowska, Sebastian Mertowski, Piotr Tomaka, Łukasz Dziki, Ewelina Grywalska. Immunological Strategies in Gastric Cancer: How Toll-like Receptors 2, -3, -4, and -9 on Monocytes and Dendritic Cells Depend on Patient Factors?. Cells 2024; 13(20): 1708 doi: 10.3390/cells13201708
|
7 |
Xili Jiang, Wei Zhang, Lifeng Li, Shucai Xie. Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.1609985
|
8 |
Wenjie Zhang, Feng Yu, Yu Wang, Yu Zhang, Lingxin Meng, Yuhua Chi. Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway. Oncology Letters 2018; doi: 10.3892/ol.2018.7949
|
9 |
Bharath Somasundram, Prasath Manogaran, Madavan Vasudevan, Vijaya Padma Viswanadha. Chemosensitizing effect of neferine on cisplatin-resistant colorectal cancer: Identification of potential candidate genes and pathways through whole transcriptome profiling. Phytomedicine Plus 2022; 2(3): 100299 doi: 10.1016/j.phyplu.2022.100299
|
10 |
Ali Niapour, Naisana Seyedasli. Acquisition of paclitaxel resistance modulates the biological traits of gastric cancer AGS cells and facilitates epithelial to mesenchymal transition and angiogenesis. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(5): 515 doi: 10.1007/s00210-022-02217-3
|